Ablative Therapies for Liver Tumors

The most common primary and metastatic liver tumors include hepatocellular carcinoma and colorectal liver metastasis, both of which remain the leading cause of cancer-related deaths worldwide. While surgical liver resection and transplantation have been considered the gold standard for curative treatment, the use of minimally invasive locoregional ablative therapies for treatment of primary and metastatic liver tumors has emerged as an alternative, increasing the chances of cure and reducing morbidity. Ablative therapies play a significant role in the management of liver tumors. Advances in technology should be used to carefully select patients and subsequent modalities to achieve best tumor outcomes.